Adaptyx Biosciences Raises $14M Seed Round Led by Interlagos Capital

Deal Summary

Adaptyx Biosciences, a Menlo Park biowearables firm developing continuous multi-analyte molecular monitoring, raised $14M in a seed round led by Interlagos Capital with participation from multiple investors, bringing total funding to $23M. The financing will support development of its molecular monitoring platform.